PLA1A and neoplasm: In these individuals/tumors which better utilize NMD mechanisms to ablate the activity of these tumor suppressor genes, applying NMD inhibition therapeutically—alone or in combination with readthrough agents [117–119]—may be promising in restoring tumor suppression activity to treat cancer.